9th International Inflammation & Immune Diseases Drug Discovery & Development Summit

This year's conference program progresses through two full days of unique scientific presentations, the first day as a general plenary, with the second day tracked into a) inflammatory and b) immune diseases which will address key issues and complexity in finding new treatments.

The Inflammation & Immune Diseases World Summit is the largest meeting of its kind and has been organized to bring together the entire community of immunology & inflammatory researchers for the first time, as they will review many of their programs intended to generate next generation drugs.

Corticosteroids - The Next Generation
Stuart Farrow, Ph.D.
Section Head, Asthma Biology, Respiratory and Inflammation Centre of Excellence
GLAXOSMITHKLINE

Role of B Cells in Autoimmune Diseases
Peter E. Lipsky, M.D.
Director, Intramural Research Program - Arthritis, Musculoskeletal & Skin Diseases
NATIONAL INSTITUTES OF HEALTH (NIH)

SCIENTIFIC ADVISORY BOARD:

Alan Lewis, Ph.D.
CEO
CELGENE SAN DIEGO

Brett Monia, Ph.D.
Vice President, Antisense Discovery
ISIS PHARMACEUTICALS

Martin Braddock, Ph.D.
Associate Director, Respiratory & Inflammation Research Area
ASTRAZENECA UK

James G. Karras, Ph.D.
Associate Director, Antisense Drug Discovery
ISIS PHARMACEUTICALS

Alvin F. Wells, M.D., Ph.D.
Director, Rheumatology
LAKESHORE MEDICAL CLINIC

9th Annual
Inflammation & Immune Diseases Drug Discovery & Development Summit

March 14 - 15, 2005

Select Pricing Option

$1,495.00 1. Standard for Delegates
$695.00 2. University/Hospital/Government Rate